… Herein we describe the properties of two new TEM-rclated enzymes discovered in
clinical isolates of … We have described the first clinical isolates of E. coli producing TEM-derived …

… In summary, this first survey shows an alarmingly high frequency of multi-resistant ESBL-PEs
among clinical isolates in Burkina Faso. The analysis of the resistance genes highlighted …

… β-lactamases have been identified in various clinical isolates, … mobilize β-lactamase-encoding
genes with these β-lactamase … -M-type β-lactamases among clinical isolates of the family …

… /β-lactamase inhibitor combination against Klebsiella isolates with extended-spectrum β-lactamases; …
We evaluated the use of other β-lactam/β-lactamase inhibitor combinations in …

… Our aim has been to determine the activity of β-lactam and non–β-lactam antibiotics in
clinical isolates of ESBL-producing strains of E. coli using an automated assay and to determine …

… of the AmpC β-lactamase has previously been documented as a prevalent mechanism of
β-lactam … of ESBLs in a consecutive sample of clinical isolates of E. cloacae andEnterobacter …

… & metallo-βlactamase production in clinical isolates … of a βlactamase inhibitor. These tests
detect and differentiate carbapenemase and metallo-β-lactamase production from other β-…

… beta-lactam resistance capable of spread by plasmid dissemination among clinical isolates.
… pl) of 8.4 which was found in 11 clinical isolates of K. pneumoniae and subsequently cloned …

The prevalence of metallo-β-lactamase (MBL) production among 104 clinical isolates of
Pseudomonas aeruginosa from northwest of Iran was investigated by phenotypic and …

… Our result show that replacing of cephalosporins with antibiotic containing β lactamase
inhibitors (piperacillin–tazobactam) may help to reduce the occurrence of ESBLs producing …